Efficacy of ayurveda medications, Brahmi vati and Saraswatarista, in generalized anxiety disorder- a randomized controlled trial.

ABSTRACT:

Background

Ayurvedic intervention (Brahmi Vati with Saraswatarista) is explored for their possible role in management of Generalized Anxiety Disorder (GAD), a common psychiatric disorder.

Objective

The objective of the study was to evaluate the efficacy of Brahmi Vati and Saraswatarista in GAD.

Methods

Study is a randomized controlled clinical trial. Patients (n = 50) of GAD (Diagnostic and Statistical Manual of Mental Disorders (DSM-5 criteria), 18-60 years of age, either sex participated in the study. Participants were randomly divided into two groups. Group A, received escitalopram 10 mg/day for first 10 days followed by 20 mg/day for next 50 days. Group B, received Ayurvedic intervention (Brahmi Vati 500 mg thrice a day (TID) and Saraswatarista 10 ml TID) for 60 d

SUBMITTER: Gonugade VB 

PROVIDER: S-EPMC11652770 | biostudies-literature | 2024 Nov-Dec

REPOSITORIES: biostudies-literature